Bendamustine package insert pdf

Ninlaro ixazomib capsules, for oral use hepatotoxicity. Hepatotoxicity see full prescribing information for complete boxed warning. No mean changes greater than 20 milliseconds were detected. The recommended dose of bendamustine is 90 mgm day on day 1 and 2 when administered with polivy and a rituximab product.

Dailymed bendeka bendamustine hydrochloride injection. Patients treated is based on the pbrer report of patient exposure, which was calculated based on the global total milligram volume sales. The reconstituted solution must be transferred to the infusion bag within 30. Highlights of prescribing information skin reactions. Highlights of prescribing information macular edema. Assure good venous access prior to starting bendeka infusion and monitor the intravenous infusion site for redness, swelling, pain, infection, and necrosis during and after. Highlights of prescribing information these highlights do not include all the information needed to use votrient safely and effectively. Highlights of prescribing information these highlights do not include all the information needed to use angiomax safely and effectively.

The resulting final concentration of bendamustine hydrochloride in the infusion bag should be within 1. The lyophilized powder should completely dissolve in 5 minutes. Highlights of prescribing information total car these. Gazyva obinutuzumab is a prescription medicine used with the chemotherapy drug, bendamustine, followed by gazyva alone for follicular lymphoma fl in adults who did not respond to a rituximabcontaining regimen, or whose fl returned after such treatment. Highlights of prescribing information palmarplantar. Bendamustine for treatment of chronic lymphocytic leukemia.

If previously receiving 60 mg daily dose, resume treatment at 40 mg daily. After a single dose of 120 mgm2 bendamustine iv over 1hour the intermediate t12 of the parent compound is approximately 40 minutes. The efficacy of bendamustine in patients with relapsed indolent bcell nhl is based on overall response. Efficacy relative to first line therapies other than chlorambucil has not been established. After transferring, thoroughly mix the contents of the infusion bag. Bendamustine hydrochloride injection is a clear and colorless to yellow solution. The onset of symptoms usually occurs within minutes to hours of receiving a new or a greater.

In combination with chemotherapy followed by gazyva. Bendamustine was approved by the united states fda in march 2008 for the treatment of cll, based on a phase iii study comparing bendamustine and chlorambucil as firstline therapy for. Bendeka bendamustine hydrochloride injection, for intravenous use initial u. Gazyva, in combination with bendamustine followed by gazyva monotherapy, is indicated for the treatment of patients with follicular lymphoma who relapsed after, or are refractory to, a rituximab containing regimen see clinical studies 14. Bendeka bendamustine hydrochloride injection is indicated for the treatment of patients with indolent bcell nonhodgkin lymphoma that has progressed during or within six months of. The nccn compendium is a derivative work of the nccn guidelines. Women should ask about reliable forms of birth control while using this medication. Vinblastine sulfate is the salt of an alkaloid extracted from vinca rosea linn. Administer polivy, bendamustine, and rituximab product in any order on day 1 of each cycle. Jan 14, 2020 120 mgm 2 infused intravenously over 10 minutes on days 1 and 2 of a 21day cycle, up to 8 cycles. The recommended dose of rituximab product is 375 mgm. Information for the user bendamustine hydrochloride 2. Full prescribing information 1 indications and usage mayzent is indicated for the treatment of relapsing forms of multiple sclerosis ms, to include clinically isolated syndrome, relapsingremitting disease, and active secondary progressive disease, in adults.

Gazyva dosing and administration guide indications gazyva is a cd20directed cytolytic antibody and is indicated. Methotrexate injection, usp is sterile and nonpyrogenic and may be given by the intramuscular, intravenous, intraarterial or intrathecal route. Bendeka is not right for everyone, including patients with a known allergic response to. Bendamustine clearance in humans is approximately 700 mlminute. Highlights of prescribing information these highlights do not. No other diluents have been shown to be compatible. Highlights of prescribing information these highlights do.

Pulmonary toxicity in a clinical investigation using fludarabine phosphate injection in combination with pentostatin deoxycoformycin for the treatment of refractory chronic lymphocytic leukemia cll in adults, there was an unacceptably high incidence of fatal pulmonary. Monitor patients and discontinue rituxan infusion for severe reactions 5. Bendamustine hydrochloride is an alkylating drug indicated for treatment of. Bendamustine hydrochloride injection is a cytotoxic drug. Bendeka bendamustine hydrochloride injection is indicated for the treatment of patients with chronic lymphocytic leukemia. Tls can cause you to have kidney failure and the need for dialysis treatment or may cause an abnormal heart rhythm. A burning sensation where the infusion needle is inserted may be a sign of. Treanda bendamustine hydrochloride injection, for intravenous use. Severe mucocutaneous reactions, some with fatal outcomes 5. Follow applicable special handling and disposal procedures.

Only the preservative free formulation of methotrexate injection, usp may be administered by the intrathecal route. Jul 05, 2018 this phase 12 study evaluated the combination of brentuximab vedotin bv plus bendamustine as a first salvage regimen in relapsedrefractory hl. Bendeka is contraindicated in patients with a history of a hypersensitivity reaction to bendamustine, polyethylene glycol 400. Efficacy relative to firstline therapies other than chlorambucil has not been established or a indolent bcell nonhodgkin lymphoma nhl that has progressed during or within six months of treatment with rituximab or a rituximabcontaining regimen. Bendeka bendamustine hcl injection information for patients. See full prescribing information for complete boxed warning. Votrient pazopanib tablets, for oral use initial u. Bendamustine hydrochloride for injection prescribing information. Only the preservative free formulation of methotrexate injection. The indications below including fdaapproved indications and. Bendeka fda prescribing information, side effects and uses. Bendamustine hcl extravasations have been reported in postmarketing resulting in hospitalizations from erythema, marked swelling, and pain.

Highlights of prescribing information central nervous. The admixture should be a clear and colorless to slightly yellow solution. Rituxan can cause serious and lifethreatening side effects, including. Your doctor should order a pregnancy test before you start this medication. Highlights of prescribing information these highlights do not include all the information needed to use cancidas safely and effectively. Jan 01, 2020 the effect of bendamustine on the qtc interval was evaluated in 53 patients with indolent nhl and mantle cell lymphoma on day 1 of cycle 1 after administration of rituximab at 375 mgm 2 intravenous infusion followed by a 30minute intravenous infusion of bendamustine at 90 mgm 2 day. Dailymed vinblastine sulfate vinblastine sulfate injection. Store bendamustine hydrochloride injection at recommended refrigerated storage conditions 2 to 8c or 36 to 46f. Eagle pharmaceuticals, inc bendamustine hydrochloride. Bendamustine is a bifunctional mechlorethamine derivative containing a purine like. Bendeka bendamustine hydrochloride injection is indicated for the treatment of patients with indolent bcell nonhodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximabcontaining regimen.

Tls is caused by the fast breakdown of cancer cells. May 01, 2019 bendamustine hydrochloride injection is a multipledose vial. It is not commonly given with the goal of cure, but to put the lymphoma in remission and keep it in remission for months to even years. Gazyva, in combination with chemotherapy followed by gazyva monotherapy in patients.

If particulate matter is observed, the reconstituted product should not be used. Stability of partially used vials needle punched vials. A total of 55 patients 28 primary refractory and 27 relapsed were enrolled. Preclinical radiolabeled bendamustine studies showed that approximately 90% of drug administered was recovered in excreta primarily in the feces. Aseptically withdraw the volume needed for the required dose based on 5 mgml concentration and immediately transfer to a 500. Monitor closely and restart treatment based on anc and platelet count recovery. The onset of symptoms usually occurs within minutes to hours of receiving a new or a greater dose of a serotonergic medication. Ten has been reported for rituximab see rituximab package insert.

Treanda 100 mg lyophilized powder in a singledose vial for reconstitution. Cases of stevensjohnson syndrome sjs and ten, some fatal, have been reported when treanda was administered concomitantly with allopurinol and other medications known to cause these syndromes. Rituxan rituximab for ra, nhl, cll, gpa, mpa, and pv. Retain the partially used vial in original package to protect from light and store refrigerated 2 to 8c or 36 to 46f if additional dose withdrawal from the same vial is intended. Bendeka is indicated for the treatment of patients with chronic lymphocytic leukemia cll or indolent bcell nonhodgkin lymphoma nhl that has progressed during or within six months of treatment with rituximab or a rituximabcontaining regimen. Full prescribing information 1 indications and usage mayzent is indicated for the treatment of relapsing forms of multiple sclerosis ms, to include clinically isolated syndrome. In combination with chemotherapy followed by gazyva monotherapy in patients achieving at least a partial remission, for the treatment of adult patients with previously untreated stage ii bulky, iii or iv follicular lymphoma fl.

Dosing and administration bendeka bendamustine hcl injection. Sections or subsections omitted from the full prescribing information are not listed. Bendamustine injection fda prescribing information, side. Fatal infusionrelated reactions within 24 hours of rituxan infusion. The resulting fina l concentration of bendamustine hcl in the infusion bag should be within 0. Infusion reactions and cardiopulmonary arrest 1 indications and usage 1.

Bendamustine was approved by the united states fda in march 2008 for the treatment of cll, based on a phase iii study comparing bendamustine and chlorambucil as firstline therapy for cll. Highlights of prescribing information infusionrelated. Treanda for injection singleuse vial containing 100 mg of bendamustine hcl as white to offwhite lyophilized powder. Bendeka is not right for everyone, including patients with a known allergic response to bendamustine, polyethylene glycol 400, propylene glycol, or monothioglycerol. Bendeka is indicated for the treatment of patients with a chronic lymphocytic leukemia cll. The admixture should be a clear, and colorless to yellow solution. Treanda bendeka belrapzo bendamustine treanda bendeka belrapzo fep clinical rationale the safety and effectiveness of these medications in patients less than 18 years of. Treanda bendamustine hydrochloride for injection fda. Learn more about bendeka bendamustine hcl injection. Product characteristics for bendeka and treanda bendamustine. Bendamustine does not contain chromophores that absorb at wavelengths 290 nm2 and therefore is not expected to be susceptible to direct photolysis by sunlightsrc. Treanda bendamustine hydrochloride for injection, for intravenous infusion. Patients treated is based on the pbrer report of patient exposure, which was calculated based on the global total milligram volume sales divided by the average dose per patient per year, based on us approved indications.

1019 740 160 751 985 1244 919 719 744 1371 1385 136 1038 1264 1289 915 894 210 1178 590 497 299 101 920 1477 547 398 853 1147 627 205 1036